System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma

BACKGROUND: Immune checkpoint inhibitors as monotherapies for advanced hepatocellular carcinoma (HCC) fail to achieve satisfying results, while combination therapies show greater efficacy. Therefore, identifying new combined targets for immune checkpoint inhibitors could be promising. METHODS: We co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Zhou, Tao, Chen, Xingyi, Wang, Yu, Ding, Yushi, Tu, Haoyang, Gao, Shengyang, Wang, Haoyu, Tang, Xinying, Yang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900045/
https://www.ncbi.nlm.nih.gov/pubmed/35246476
http://dx.doi.org/10.1136/jitc-2021-004414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900045/
https://www.ncbi.nlm.nih.gov/pubmed/35246476
http://dx.doi.org/10.1136/jitc-2021-004414

Ejemplares similares